Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Outreach Services with a Health Specialism for People Rough Sleeping in the UK: An Intervention Optimisation Study
The study develops and optimises a health‑specialist outreach model for people rough sleeping in England, producing a detailed programme theory and operational plan. Using rapid evidence review, stakeholder workshops, and interviews, researchers identified system inhibitors such as local population differences, limited organisational capacity, and scarce follow‑on services. Recommendations include integrating lived‑experience voices, trauma‑informed training, tailored outreach, peer‑led supervision, and enhanced data flows, with nurses attending client appointments. The optimised model will be tested in a pilot cluster RCT with economic and process evaluations.
Major Leap Towards Reanimation After Death as Mammal's Brain Preserved
Researchers at Nectome have successfully cryopreserved an entire pig brain, locking cellular activity with minimal damage. The method uses rapid vitrification to prevent ice formation, preserving neural architecture and synaptic connections. Nectome now plans to offer the service to terminally...
Confusion Swirls Over ACIP, Vaccine Policy Future After Court Ruling
A federal court has halted the CDC’s Advisory Committee on Immunization Practices (ACIP) recommendations, throwing the Trump administration’s vaccine policy into uncertainty. Officials are weighing whether to appeal the decision or dissolve the current panel and appoint new members. The...
When Illness Means Crossing Seas to Survive
The article uses a grieving employee’s story to expose the Philippines’ fragmented healthcare system, where families from remote islands must cross seas for treatment. Limited provincial facilities force costly, time‑consuming journeys that often delay life‑saving care. Lawmakers are pushing legislation...
Notices of Updates
The FDA released a series of updates between 2020 and 2026 that revise, recognize, or withdraw antimicrobial susceptibility breakpoints and standards for dozens of drugs. Recent actions include recognizing M100 MIC and disk‑diffusion breakpoints for amikacin, cefiderocol, and several beta‑lactam...
CBS News Exposes $105 Million Medicare Hospice Fraud in Los Angeles County
CBS News' investigation identified more than 700 of the 1,800 licensed hospice providers in Los Angeles County as participants in a Medicare fraud scheme that overbilled the program by $105 million in a single year. The report highlights a dramatic surge...
Antifungal Susceptibility Test Interpretive Criteria
The FDA has formally recognized Clinical and Laboratory Standards Institute (CLSI) performance standards for antifungal susceptibility testing, specifically the 2026 editions of M27M44S for yeasts and M38M51S for filamentous fungi. The agency lists which antifungal drugs have approved susceptibility test...
Flu Deaths Surge: 85% of Kids Unvaccinated
1. A #flu update: 14 more kids have died from flu this season, per #CDC. This brings the 2025-26 pediatric flu death tally to 115 so far but it's likely to continue to rise. At this point last year the...
The Secret Sauce of Leadership Trust in Health Care Teams
The article argues that trust is the "secret sauce" for high‑performing health‑care teams, linking neuroscience to better collaboration, reduced burnout, and superior patient care. It presents Harvard Business School professor Frances Frei’s three‑pillar framework—authenticity, logic, and empathy—as practical levers for...
Health Gorilla and GuardDog Telehealth Set the Record Straight
Health Gorilla released a case study and 21 recorded meetings confirming that GuardDog consistently represented its telehealth services as treatment‑focused, covering chronic care management and patient monitoring. The materials span July 2024 to November 2025 and counter claims that GuardDog’s data queries...
Health Gorilla and GuardDog Telehealth Set the Record Straight
Health Gorilla released a case study and 21 recorded meetings showing GuardDog consistently described its services as treatment‑focused telehealth. The materials confirm GuardDog’s claim that all data queries were made under HIPAA authorizations to support patient care, not for non‑treatment...
In the Clinic for March 20, 2026
The March 20, 2026 "In the Clinic" page aggregates a wide array of BioWorld snapshots, special reports, and infographics covering biopharma, medical technology, and emerging therapeutic areas. It links to daily data snapshots, market outlooks, and deep‑dive analyses such as the med‑tech...
Study: Antibiotics Can Disrupt Gut Microbiome for Years
A large Swedish cohort study published in Nature Medicine shows that antibiotics can disturb the gut microbiome for up to eight years, with the most pronounced changes occurring within the first year. The research, which analyzed fecal metagenomes of 14,979...
Living-Cell Robots Gain Self-Contained Nervous Systems
Robots Made From Living Cells Get Upgraded With Their Very Own Nervous Systems https://t.co/ctQ64b45O4 https://t.co/ye1TV6VwCn
‘Generation at Risk’: AASLD Backs Court Order Upholding Childhood Hepatitis A, B Vaccines
The U.S. District Court temporarily blocked the Trump administration’s effort to revise the CDC childhood immunization schedule, preserving universal hepatitis B birth‑dose and routine hepatitis A vaccinations. The American Association for the Study of Liver Diseases (AASLD) backed the ruling after months...
Female Reproductive Cancers Are Narrowing the Sex Gap in Life Expectancy
New research analyzing 264 million deaths in 20 high‑income countries finds that women aged 35‑60 experience higher mortality from breast and other reproductive cancers than men, eroding their overall longevity advantage. The authors introduced the Truncated Cross‑Sectional Average Length of Life...
Patients Should Expect Doctors to Use Clinical AI
At this point, it's very reasonable for a patient to ask their doctor, "Have you used clinical AI to help optimize your diagnosis and treatment plan for me?"
FAQs on IPF Therapies: Current, Emerging, and Combination Strategies
Idiopathic pulmonary fibrosis (IPF) treatment now includes three FDA‑approved antifibrotic drugs—nerandomilast, nintedanib, and pirfenidone—each shown to slow forced vital capacity decline. Nerandomilast, approved in 2025, marks the first new IPF therapy in over a decade, while cost‑effectiveness analyses favor nintedanib...
LHMC Installs Medical Automation Software
Able Innovations has partnered with Lahey Hospital & Medical Center (LHMC) to launch the ALTA Platform, a robotic patient‑handling system, as the first U.S. deployment of the technology. The platform automates lateral patient transfers, lowering caregiver injury risk while boosting...
Health Experts Discuss Vaccine Shifts, Funding, ACA, and Solutions
On this week's #WTHealth pod: @LaurenWeberHP, @sangerkatz, and @AliceOllstein on vaccine changes, NIH funding, the ACA and more. Plus @DrewAltman kicks off our new series, "How Would You Fix It?" https://t.co/GYkk11Hv6L
The New Chapter Added to My Vaccine Book
Dr. Gator’s latest update adds a new chapter to *Between a Shot and a Hard Place*, reflecting a year of rapid shifts in U.S. vaccine policy, legal battles, and scientific debate. The chapter details CDC schedule changes that now mirror...
Companies Hide Device Risks, Harm Thousands
This is a recurrent fiasco. Health care companies that now the serious risk of their device or drug but keep selling it and do not acknowledge the hazard. Until so many people are harmed. Today's front page @nytimes by @katie_thomas @bostonsci...
Understanding Community and Health System Acceptability, Readiness and Perspectives on the Introduction of New Vector Control Approaches for Malaria Control...
Malaria remains a leading health threat in Papua New Guinea, prompting the NATNAT project to evaluate supplementary vector control tools such as residual indoor spraying, spatial emanators, and larval source management. A qualitative study across four Madang Province villages used...
Phoenix Hospital Group Launches New Prostate MRI Cancer Screening Service
Phoenix Hospital Group has launched a Prostate MRI Cancer Screening Service at its Harley Street hospital in London and at Phoenix Chelmsford Hospital, with the offering also extended to its Hatfield and Ashford sites. The package includes an in‑person urologist...
5 Things to Know About Pediatric Health Coaching and the Obesity Care Gap
Pediatric health coaching is being promoted as a workforce‑driven strategy to bridge the gap between clinical guidelines and real‑world behavior change for childhood obesity. Experts from the Pediatric Health Coach Academy argue that intensive, family‑based programs are proven effective yet...
FAQs About AI in Radiology: Legal Risks, Liability, and Malpractice
Artificial intelligence is rapidly entering radiology, yet U.S. malpractice law still places physicians at the center of liability, even when AI tools err. Recent studies show jurors are more likely to hold radiologists responsible if they contradict an AI system,...
Income Associated With Health System Performance Disparities in US, South Korea
A new JAMA Health Forum analysis compares income‑related health system performance disparities in the United States and South Korea. Using MEPS, NHANES, KHPS and Korean NHANES data for over 400,000 adults, researchers examined spending, utilization, access, health status, risk factors...
UK’s NICE Revisits Lilly, Eisai Alzheimer's Drugs Under New Pricing Threshold
The UK’s National Institute for Health and Care Excellence (NICE) has reopened its evaluation of Eli Lilly’s donanemab and Eisai’s lecanemab after initially rejecting them on cost grounds. A newly‑introduced cost‑effectiveness threshold of roughly £20,000 per quality‑adjusted life year (QALY)...
Despite New Federal Actions, Prescription Drug Worry Hits Highest Level Since 2018
A new KFF poll finds that 41 % of U.S. adults think the Trump administration’s TrumpRx initiative will lower prescription drug costs, but confidence is split sharply along party lines. Overall worry about affording medications has risen to its highest level...
Saluja Medical Associates Gains ROI with Remote Workforce Platform
Saluja Medical Associates adopted Edge’s secure remote workforce platform, embedding eight to ten certified virtual assistants to handle insurance verification, scheduling, billing and call support. The model eliminated lengthy local hiring cycles, reduced turnover, and ensured compliance through supervised campus...
Q&A: Patients with Eczema Continue to Face Insurance Barriers
Patients with eczema continue to encounter significant insurance obstacles, according to a 2025 National Eczema Association (NEA) survey. The study found that 40% of respondents experienced coverage issues, 15% never began prescribed therapy, and step‑therapy and prior‑authorization requirements delayed treatment...
US Plasma Sales Power Billion‑Dollar Industry, Aid Lives
The US lets people sell their blood plasma, creating a multibillion-dollar industry (70% of global supply, 62.5M liters donated, $6.2B in exports) that saves countless lives and gives Americans a safe way to make a little cash (thus reducing their...
Biotech Godfather Stelios Papadopolous Joins Garde on Podcast
This week's Readout LOUD podcast is now available on all your favorite podcast outlets -- Stelios Papadopolous, the ‘godfather’ of biotech, in conversation with @damiangarde https://t.co/RHh5Qv9OyT via @statnews
Refractive IOL Surgery: Closing in on a Zero Enhancement Rate
Dr. James R. Kelly reports that enhancement rates for presbyopia‑correcting intraocular lenses have dropped from double‑digit levels in the early 2000s to roughly 5% by 2020, thanks to advances in lens optics and surgical technique. Residual refractive error under 0.5...
AI-Enabled Device Provides Early Health Warnings
Cherish unveiled an AI‑enabled wearable that continuously records patient vitals such as heart rate and respiration. The device applies machine‑learning algorithms to establish individual baselines and flag subtle deviations that may signal health deterioration. Clinicians receive early alerts, enabling proactive...
Higher Fitness Linked to Lower Dementia, Depression, Psychosis Risk
The relationship between increased cardiorespiratory fitness (METS) and reduced risk of all-cause dementia, depression, and psychotic disorders. From over 4 million individuals in 27 studies @NatMentHealth [association, not cause and effect evidence] https://t.co/iQdGRc0Nrz
I Was at Ground Zero for the AIDS Epidemic. RFK's Cuts Could Fuel a New Pandemic, Just when Elimination Seemed...
Robert F. Kennedy Jr., as HHS secretary, slashed $759 million in HIV research grants, eliminated half of the CDC’s HIV‑prevention divisions and redirected oversight to a new agency, jeopardizing a program that had driven new infections down more than 90 %. At...
Two Conduction-System Pacing RCTs Give Conflicting Results
Two randomized trials comparing conduction‑system pacing (CSP) with traditional biventricular (BiV) cardiac resynchronization therapy produced opposite results. The Chinese HeartSync‑LBBP study found that left‑bundle branch pacing reduced the composite of death or heart‑failure hospitalization and improved ventricular remodeling, while the...
Tumor Whole-Genome Sequencing Influences Care in 40%+ Patients
Why should tumor whole genome sequencing (WGS) be done for cancer? In real practice of medicine study of 888 patients with solid cancers, WGS directly led to clinical consequences in over 40% @NatureMedicine https://t.co/kFho0yuLS7
Biotech Giant Earendil Labs Secures $787M Funding
Giant biotech round that hit right after I sent Pro Rata: Earendil Labs raises $787M https://t.co/NWt2bBA9Lr
GLP-1 Microdosers Are Chasing Longevity
A recent Evidation survey shows roughly one in seven U.S. adults on GLP‑1 drugs are microdosing, often to curb costs or chase longevity benefits without full‑dose side effects. Clinics like AgelessRx now market low‑dose regimens, while some physicians prescribe them...
Prasad’s CBER Saw Frequent Overrules, Unlike Rest of FDA
caveat here is that it was routine when Prasad ran CBER (at least 4 overrules in Prasad's 10 mo. tenure) but it didn't/doesn't still seem to be happening elsewhere in FDA
Mechanically Enhanced, Antibacterial, and Double‐Network Hydrogel Flexible Sensors for Sleep Apnea Monitoring
Researchers have engineered a multifunctional hydrogel sensor by integrating a polyvinyl alcohol/silk fibroin double network with tannic‑acid‑coated liquid metal droplets, copper particles, and an ethanol post‑treatment. The resulting material exhibits a tensile strength of 1.452 MPa—483% higher than pure PVA—alongside 700%...
Healthcare AI Is Deployed Nationwide. Governance Isn’t Ready
Healthcare AI is already reshaping clinical workflows, but governance lags behind. The FDA has cleared more than 1,400 AI‑enabled devices, yet post‑deployment monitoring remains weak, creating safety gaps. Industry leaders and the U.S. Senate are calling for national datasets and...
Former FDA Chief Warns Political Pressure Plagued Trump Era
Political influence ‘a serious problem’ for FDA under Trump, former commissioner says https://t.co/52IR3LfECD via @statnews
FDA Issues Class II Recall of 89,592 Bottles of Children's Ibuprofen Over Contamination
The U.S. Food and Drug Administration has ordered a Class II recall of 89,592 bottles of 100‑mg/5‑ml Children’s Ibuprofen Oral Suspension after consumers reported gel‑like masses and black particles. The product, manufactured by India‑based Strides Pharma for Taro Pharmaceuticals USA, was...
HIMSSCast: Nurturing National Standards for AI in Patient Care
The HIMSSCast episode spotlighted a new Nursing and Artificial Intelligence Innovation Consortium aimed at creating national standards for AI in patient care. Speakers emphasized that many AI tools succeed in labs but falter in real‑world nursing workflows, diverting clinicians from...
Promising Therapeutics' Future at Risk Under Trump FDA
The future of promising therapeutics is on the line in the Trump administration's FDA, says the agency's former commissioner https://t.co/vyt49FkDsb
MPs Committee: This Is What Ails SHA
The National Assembly health committee warned that Kenya's Social Health Authority (SHA) is financially unsustainable, collecting roughly Sh7.4 billion monthly but spending Sh7.2 billion on operations. Only about 5 million of the 29 million registered members actually remit premiums, creating a large funding gap....
Kent Meningitis Outbreak May Have Peaked as UKHSA Reports Slowdown in Cases
The UK Health Security Agency reported that the meningitis outbreak in Kent appears to have peaked, with only two new cases reported on Friday. To date, 18 confirmed and 11 probable cases have been recorded, totaling 29 infections, of which...